A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo.
- 1 January 1999
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 16 (1), 155-160
- https://doi.org/10.1023/a:1018847501985
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Encapsulation of vasoactive intestinal peptide into liposomes: Effects on vasodilation in vivoLife Sciences, 1995
- Vasoactive intestinal peptide encapsulated in liposomes: Effects on systemic arterial blood pressureLife Sciences, 1994
- Nitric oxide regulates peptide release from parasympathetic nerves and vascular reactivity to vasoactive intestinal polypeptide in vivoEuropean Journal of Pharmacology, 1994
- Partitioning of vasoactive intestinal polypeptide into lipid bilayersBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- The L-Arginine-Nitric Oxide PathwayThe New England Journal of Medicine, 1993
- Vasoactive intestinal peptide: Its interactions with calmodulin and catalytic antibodiesNeurochemistry International, 1993
- Peptidergic innervation of human epicardial coronary arteries.Circulation Research, 1993
- Nitric oxide synthase in VIP-containing vasodilator nerve fibres in the GuineapigNeuroReport, 1992
- VIP receptors in mesenteric and coronary arteries: A radioligand binding studyPeptides, 1987
- Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptidePeptide Science, 1982